NeoGenomics and Zacks Investment Research

Selected Headlines

Date Headline (link) Source Relevant Snippet
9/20/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives $52.81 Consensus Target Price from Brokerages NeoGenomics, Inc. (NASDAQ:NEO) has earned a consensus rating of ‚AuBuy‚Au from the eleven research firms that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold ... Au rating and a $55.00 price objective for the company. Zacks Investment Research upgraded NeoGenomics from a ‚Ausell‚Au rating to a ‚Auhold‚Au rating in a research note on Tuesday, August 17th. Finally, Benchmark ...
9/20/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives $52.81 Consensus Target Price from Analysts NeoGenomics, Inc. (NASDAQ:NEO) has been given a consensus recommendation of ‚AuBuy‚Au by the eleven analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold ... of NeoGenomics in a research note on Monday, August 9th. Zacks Investment Research raised shares of NeoGenomics from a ‚Ausell‚Au rating to a ‚Auhold‚Au rating in a research note on Tuesday, August 17th ...
9/13/2021 NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Quarterly Sales of $126.27 Million Wall Street brokerages expect NeoGenomics, Inc. (NASDAQ:NEO) to post $126.27 million in sales for the current fiscal quarter, according to Zacks . Three analysts have provided estimates for NeoGenomics‚Ao earnings. The highest sales estimate ... million, with estimates ranging from $569.26 million to $594.13 million. Zacks Investment Research‚Aos sales averages are an average based on a survey of research analysts that that provide coverage for NeoGenomics. NEO has been ...
9/13/2021 Analysts Expect NeoGenomics, Inc. (NASDAQ:NEO) Will Post Quarterly Sales of $126.27 Million Equities research analysts predict that NeoGenomics, Inc. (NASDAQ:NEO) will announce $126.27 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for NeoGenomics‚Ao earnings, with estimates ranging from $125.14 million to $127.20 million. NeoGenomics posted sales of $125.44 million during the same quarter last year, which suggests a positive year over year growth rate of 0.7%. The company is scheduled to announce ...
9/13/2021 NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Quarterly Sales of $126.27 Million - Mayfield Recorder Mayfield Recorder Brokerages expect that NeoGenomics, Inc. (NASDAQ:NEO) will report $126.27 million in sales for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for NeoGenomics‚Ao earnings, with the highest sales estimate coming ... million, with estimates ranging from $569.26 million to $594.13 million. Zacks Investment Research‚Aos sales calculations are an average based on a survey of sell-side analysts that that provide coverage for NeoGenomics.Get NeoGenomics ...
9/13/2021 $126.27 Million in Sales Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter - WKRB News Wall Street analysts expect that NeoGenomics, Inc. (NASDAQ:NEO) will announce sales of $126.27 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for NeoGenomics‚Ao earnings, with estimates ranging from $125.14 million to $127.20 million. NeoGenomics posted sales of $125.44 million in the same quarter last year, which suggests a positive year over year growth rate of 0.7%. The firm is scheduled to ...
9/12/2021 NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages American Banking News NeoGenomics, Inc. (NASDAQ:NEO) has received an average rating of ‚AuBuy‚Au from the eleven research firms that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold ... A number of equities analysts have commented on the stock. Zacks Investment Research raised shares of NeoGenomics from a ‚Ausell‚Au rating to a ‚Auhold‚Au rating in a report on Tuesday, August 17th. Benchmark ...
9/12/2021 NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages - Stock Observer NeoGenomics, Inc. (NASDAQ:NEO) has received an average rating of ‚AuBuy‚Au from the eleven research firms that are covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold ... A number of equities analysts have commented on the stock. Zacks Investment Research raised shares of NeoGenomics from a ‚Ausell‚Au rating to a ‚Auhold‚Au rating in a report on Tuesday, August 17th. Benchmark ...
9/11/2021 Analysts Expect NeoGenomics, Inc. (NASDAQ:NEO) to Post -$0.08 EPS Wall Street analysts forecast that NeoGenomics, Inc. (NASDAQ:NEO) will post earnings of ($0.08) per share for the current fiscal quarter, according to Zacks Investment Research . Three analysts have made estimates for NeoGenomics‚Ao earnings, with the lowest EPS estimate coming in at ($0.10) and the highest estimate coming in at ($0.05). NeoGenomics posted earnings of $0.06 per share in the same quarter last year, which suggests a negative year ...
9/10/2021 NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Quarterly Sales of $126.27 Million - Ticker Report Ticker Report Brokerages expect NeoGenomics, Inc. (NASDAQ:NEO) to post $126.27 million in sales for the current quarter, Zacks reports. Three analysts have issued estimates for NeoGenomics‚Ao earnings, with the lowest sales estimate coming in at ... for the company in a report on Monday, August 9th. Zacks Investment Research raised shares of NeoGenomics from a ‚Ausell‚Au rating to a ‚Auhold‚Au rating in a report on Tuesday, August 17th. The ...
9/10/2021 Brokerages Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Announce Earnings of -$0.08 Per Share - The Cerbat Gem Equities analysts predict that NeoGenomics, Inc. (NASDAQ:NEO) will announce earnings of ($0.08) per share for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for NeoGenomics‚Ao earnings, with the lowest EPS estimate coming in at ($0.10) and the highest estimate coming in at ($0.05). NeoGenomics posted earnings of $0.06 per share in the same quarter last year, which would indicate a negative year-over-year ...
9/9/2021 Zacks: Brokerages Expect NeoGenomics, Inc. (NASDAQ:NEO) Will Post Quarterly Sales of $126.27 Million The Markets Daily Analysts expect NeoGenomics, Inc. (NASDAQ:NEO) to announce sales of $126.27 million for the current fiscal quarter, according to Zacks Investment Research . Three analysts have made estimates for NeoGenomics‚Ao earnings, with the lowest sales estimate coming in at $125.14 million and the highest estimate coming in at $127.20 million. NeoGenomics posted sales of $125.44 million in the same quarter last year, which suggests a positive year over year growth ...
9/8/2021 NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Earnings of -$0.07 Per Share - Transcript Daily Brokerages forecast that NeoGenomics, Inc. (NASDAQ:NEO) will announce earnings per share of ($0.07) for the current fiscal quarter, according to Zacks Investment Research . Three analysts have provided estimates for NeoGenomics‚Ao earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.09). NeoGenomics reported earnings per share of $0.06 in the same quarter last year, which would indicate a negative year-over-year growth rate of 216.7%. The ...
9/8/2021 $126.27 Million in Sales Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter - Stock Observer Brokerages expect that NeoGenomics, Inc. (NASDAQ:NEO) will report $126.27 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for NeoGenomics‚Ao earnings, with estimates ranging from $125.14 million to $127.20 million. NeoGenomics reported sales of $125.44 million in the same quarter last year, which indicates a positive year-over-year growth rate of 0.7%. The firm is expected to report its next ...
9/6/2021 Analysts Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Post Earnings of -$0.07 Per Share Wall Street analysts forecast that NeoGenomics, Inc. (NASDAQ:NEO) will report earnings per share of ($0.07) for the current quarter, according to Zacks Investment Research . Three analysts have made estimates for NeoGenomics‚Ao earnings, with the highest EPS estimate coming in at ($0.05) and the lowest estimate coming in at ($0.09). NeoGenomics reported earnings per share of $0.06 in the same quarter last year, which would suggest a negative year ...
9/6/2021 Analysts Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Announce Earnings of -$0.07 Per Share Brokerages expect NeoGenomics, Inc. (NASDAQ:NEO) to announce earnings of ($0.07) per share for the current fiscal quarter, according to Zacks Investment Research . Three analysts have provided estimates for NeoGenomics‚Ao earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.09). NeoGenomics reported earnings of $0.06 per share in the same quarter last year, which would suggest a negative year over year growth rate of 216.7%. The firm ...
9/6/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance - Stock Observer NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings per share estimate of ... a buy rating in a report on Thursday, August 26th. Zacks Investment Research upgraded NeoGenomics from a sell rating to a hold rating in a report on Tuesday, August 17th. Needham & Company LLC restated a ...
9/5/2021 NeoGenomics, Inc. (NASDAQ:NEO) Expected to Announce Quarterly Sales of $126.27 Million American Banking News Equities analysts expect that NeoGenomics, Inc. (NASDAQ:NEO) will report sales of $126.27 million for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for NeoGenomics‚Ao earnings, with estimates ranging from $125.14 million to $127.20 million. NeoGenomics posted sales of $125.44 million in the same quarter last year, which suggests a positive year-over-year growth rate of 0.7%. The company is expected to announce its ...
9/5/2021 NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Quarterly Sales of $126.27 Million - Transcript Daily Wall Street brokerages forecast that NeoGenomics, Inc. (NASDAQ:NEO) will announce sales of $126.27 million for the current quarter, Zacks reports. Three analysts have issued estimates for NeoGenomics‚Ao earnings, with the highest sales estimate ... million, with estimates ranging from $569.26 million to $594.13 million. Zacks Investment Research‚Aos sales averages are a mean average based on a survey of analysts that cover NeoGenomics.Get NeoGenomics alerts: Several research analysts ...
9/4/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance Mayfield Recorder NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings per share estimate of ... the stock in a research report on Monday, August 9th. Zacks Investment Research upgraded shares of NeoGenomics from a sell rating to a hold rating in a report on Tuesday, August 17th. Needham & Company LLC ...
9/4/2021 JPMorgan Chase & Co. (NYSE:JPM) Shares Bought by Texas Capital Bank Wealth Management Services Inc. | Daily Political Daily Political NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus estimate of $-0.210. The ... shares of NeoGenomics in a report on Monday, August 9th. Zacks Investment Research raised shares of NeoGenomics from a sell rating to a hold rating in a report on Tuesday, August 17th. The Goldman Sachs ...
9/4/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings per share estimate of ... buy rating and a $55.00 price target on the stock. Zacks Investment Research raised shares of NeoGenomics from a sell rating to a hold rating in a research report on Tuesday, August 17th. Morgan Stanley ...
9/3/2021 Brokerages Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Announce Earnings of -$0.07 Per Share - WKRB News Wall Street brokerages expect that NeoGenomics, Inc. (NASDAQ:NEO) will report earnings of ($0.07) per share for the current fiscal quarter, according to Zacks Investment Research . Three analysts have issued estimates for NeoGenomics‚Ao earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.09). NeoGenomics posted earnings per share of $0.06 during the same quarter last year, which would suggest a negative year over year growth rate of ...
9/3/2021 NeoGenomics (NASDAQ:NEO) Releases FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus estimate of $-0.210. The ... buy rating and a $55.00 price objective on the stock. Zacks Investment Research raised NeoGenomics from a sell rating to a hold rating in a research report on Tuesday, August 17th. Finally, Benchmark upped their ...
9/3/2021 Brokerages Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Announce Earnings of -$0.07 Per Share American Banking News Wall Street brokerages expect that NeoGenomics, Inc. (NASDAQ:NEO) will report earnings of ($0.07) per share for the current fiscal quarter, according to Zacks Investment Research . Three analysts have issued estimates for NeoGenomics‚Ao earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.09). NeoGenomics posted earnings per share of $0.06 during the same quarter last year, which would suggest a negative year over year growth rate of ...